Head-to-head comparisons of medication uses, side effects, warnings, and more.
Sunlenca (lenacapavir) is the first FDA-approved, twice-yearly injectable medication used for hard-to-treat human immunodeficiency virus (HIV) infections. It's injected under the skin on the belly by a healthcare provider every 6 months (after the starting dose is finished). Sunlenca (lenacapavir) is available as either an injection or a tablet, but the tablet form is only taken at the start of treatment. The most common side effects people experienced with Sunlenca (lenacapavir) involved reactions at the injection site, including swelling, pain, and redness.
Yeztugo (lenacapavir) works as an HIV-1 capsid inhibitor. It's used for pre-exposure prophylaxis (PrEP) to lower your risk of getting human immunodeficiency virus (HIV) from sex. It's for HIV-negative adults and adolescents who weigh at least 77 lbs at risk of getting HIV. Yeztugo (lenacapavir) starts with two injections under the skin plus tablets taken by mouth on day 1, then only tablets on day 2. After that, you get two injections every 6 months. If an injection will be late, you might need to take the tablets once weekly as a temporary bridge. Side effects include injection site reactions and headache.
Human immunodeficiency virus type 1 (HIV-1) infection in people who've received HIV medications in the past, and:
Injection site reactions:
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.